在直肠癌全新辅助疗法期间,T细胞和内皮细胞的重塑
Qianqian Gao1, Xinnan Ling2, Leen Liao3
1Institute for Data-Driven Tumor Immunology, Chongqing Medical University, Chongqing 400016, China; Institute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen 518132, China.
Cancer cell
|November 7, 2025
概括
总的新辅助疗法 (TNT) 通过改变瘤微环境来增强直肠癌治疗. 它减少了调节性T细胞,并增强了CD8+T细胞,促进了免疫反应,并可能改善完整反应率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 总的新辅助疗法 (TNT) 是局部晚期直肠癌 (LARC) 的标准.
- 免疫系统对TNT有效性的作用尚未完全理解.
- 了解瘤微环境 (TME) 变化对于优化LARC治疗至关重要.
研究的目的:
- 为了研究LARC中TNT的免疫重塑机制.
- 描述不同新辅助疗法后的TME动态.
- 为了发现TNT诱导的特定免疫细胞和内皮细胞相互作用.
主要方法:
- 单细胞RNA测序的一个细胞.
- 测序T细胞受体的测序
- 空间转录基因组序列的测序
- 来自LARC患者的治疗前和治疗后匹配样本的分析.
主要成果:
- 在TME中,TNT显著减少了调节性T细胞.
- 在TNT后观察到,产生IFNG的CD8+效应因子记忆T细胞的丰度增加.
- 在CD8+ T细胞透和ACKR1+内皮细胞之间发现了相关性.
- 激活的CD8+ T细胞和内皮细胞参与抗原呈现和T细胞激活.
结论:
- 通过调节T细胞种群和促进抗瘤免疫力,TNT重塑TME.
- CD8+ T 细胞和内皮细胞之间的相互作用是TNT有效性的关键机制.
- 这些发现为LARC中TNT反应的免疫基础提供了洞察力.
更多相关视频
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
6.4K
10:54Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol
Published on: April 4, 2018
15.9K
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
